Viewing StudyNCT00004922



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004922
Status: COMPLETED
Last Update Posted: 2013-06-19
First Post: 2000-03-07

Brief Title: Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Conditions & Keywords Data

Conditions:
Name
Neuroendocrine Carcinoma of the Skin
Carcinoma of Unknown Primary
Neuroendocrine Carcinoma
Keywords:
Name View
neuroendocrine carcinoma View
newly diagnosed carcinoma of unknown primary View
recurrent carcinoma of unknown primary View
stage III neuroendocrine carcinoma of the skin View
recurrent neuroendocrine carcinoma of the skin View